Results 41 to 50 of about 2,297,524 (233)
The Clinical Utility of Autoantibodies in Patients with Idiopathic Granulomatous Mastitis
Journal of Investigative Surgery, 2022 Background Although the etiopathogenesis of idiopathic granulomatous mastitis (IGM) is still controversial, recently autoimmunity and immune dysregulation have been emphasized.
Hande Koksal
doaj +1 more source
JKKI (Jurnal Kedokteran dan Kesehatan Indonesia), 2023 Covid-19 Convalescent Plasma (CCP) was one of alternative therapy for Covid-19 patients. The use of convalescent plasma as an adjunct therapy must consider its efficacy, benefits, and risk, both for the patient and the donor.
Teguh Triyono +4 more
doaj +1 more source
Reumatismo, 2011 Objective: To assess the role of anti-cyclic citrullinated peptide (CCP) antibody detection in synovial fluid (SF) of RA patients compared to OA patients.
G. Valesini +4 more
doaj +1 more source
7- DIAGNOSTIC VALUE OF ANTIBODIES TO CITRULLINE CONTAINING PEPTIDES IN PATIENTS WITH RHEUMATOID ARTHRITIS IN SOUTHERN IRAQ43 [PDF]
Basrah Journal of Surgery, 2009 A serological study has been done in Al-Nassiriyha, southern Iraq, from December 2006 to August 2007 designed to determine the frequency of anti-cyclic citrullinated peptide antibody (anti-CCP) in a group of patients with rheumatoid arthritis for ...
THURAYA J MEZAL +3 more
doaj +1 more source
Mediators of Inflammation, 2007 Anti-cyclic citrullinated peptide (CCP) antibody is a useful marker for the diagnosis and prognosis of rheumatoid arthritis (RA). Recently, clinical significance of follow-up in anti-CCP antibody titer has been pointed out.
Toshiaki Kogure +4 more
doaj +1 more source
Diagnostic utility of Anti-cyclic Citrullinated Peptide Antibodies for Very Early Rheumatoid Arthritis [PDF]
National Journal of Laboratory Medicine, 2014 Background and Objectives: Rheumatoid arthritis (RA) is a systemic autoimmune disorder characterized by widespread joint inflammation with synovial hyperplasia. The most well known diagnostic marker is rheumatoid factor (RF).However; RF is not a good
Sucilathangam G, Anna T, Velvizhi G
doaj +1 more source
PLoS ONE, 2022 The novel coronavirus, SARS-CoV-2 that causes COVID-19 has resulted in the death of nearly 4 million people within the last 18 months. While preventive vaccination, and monoclonal antibody therapies have been rapidly developed and deployed, early in the ...
Natasha M Clark +7 more
doaj +2 more sources
Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis [PDF]
QJM, 2007 Rheumatoid arthritis is both common and chronic, with significant consequences for multiple organ systems. Better understanding of its pathophysiology has led to the development of targeted therapies that have dramatically improved outcomes. The key to therapeutic success lies in identifying individuals who will have severe destructive disease as early
T B, Niewold, M J, Harrison, S A, Paget
openaire +2 more sources
HLA-B*08 identified as the most associated MHC locus for anti-carbamylated protein antibody-positive/anti-CCP-negative rheumatoid arthritis [PDF]
, 2021 Objective: Previously, only the HLA-DRB1 alleles have been assessed in rheumatoid arthritis (RA). The aim of the present study was to identify the key major histocompatibility complex (MHC) susceptibility factors showing a significant association with ...
Fernández-Gutiérrez, B. +27 more
core
Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion
Frontiers in Immunology, 2021 BackgroundTransfusion of COVID-19 convalescent plasma (CCP) containing high titers of anti-SARS-CoV-2 antibodies serves as therapy for COVID-19 patients. Transfusions early during disease course was found to be beneficial.
Oliver F. Wirz +23 more
doaj +1 more source